Patent 11576046

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

Active provider: Google · gemini-2.5-flash

Proceedings on file (1)

All PTAB activity →

AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.

Current assignee: Unified Patents

1 discretionary denial
Discretionary Denial
Filed
Jan 13, 2026
Last modified
May 6, 2026
Petitioner
Cisco Systems, Inc.
Patent owner
Damaka, Inc.
Outcome
Institution Denied

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

✓ Generated

Proceedings overview

One AIA trial proceeding has been filed against US patent 11576046. This proceeding is currently in a "Discretionary Denial" status, meaning the petition was not instituted, and no claims were challenged on the merits. This gives a defendant a posture where the patent's claims remain untested by the PTAB.

IPR2026-00209 — Cisco Systems, Inc. v. Damaka Inc.

  • Type: Inter Partes Review
  • Filed: 2026-01-13
  • Status: Discretionary Denial — The PTAB declined to institute the Inter Partes Review, meaning the trial on the merits of the patentability challenges did not proceed.
  • Judge panel: Vice Chief Judge Jones, Administrative Patent Judge Roesel, and Administrative Patent Judge Bahr
  • Petition grounds: The petition challenged claims 1-20 of U.S. Patent No. 11,576,046. The grounds for unpatentability were asserted under 35 U.S.C. § 103 over combinations of various prior art references, including U.S. Patent Publication No. 2008/0172709 (Averbuch), U.S. Patent No. 9,027,032 (Chaturvedi '032), and U.S. Patent Publication No. 2012/0179780 (Shum).
  • Institution decision: Denied on 2026-05-06. The PTAB exercised its discretion to deny institution under 35 U.S.C. § 314(a) based on its analysis of relevant factors, including parallel district court litigation, applying the Fintiv framework. The PTAB found that the asserted claims were directed to similar subject matter as claims in a related district court case, and that a district court trial was scheduled before a final written decision in the IPR would be due.
  • Final Written Decision: Not applicable, as the petition for IPR was denied institution.
  • Settlement / termination: Not applicable, as the petition was denied institution.
  • Appeal: No appeal was filed, as the petition was denied institution.
  • Defensive value: The discretionary denial of this IPR means that claims 1-20 of US11576046 have not been found unpatentable by the PTAB. While the specific prior art grounds raised by Cisco Systems, Inc. were not tested on the merits, the denial was procedural and not a substantive ruling on the patentability of the claims. This makes an IPR-based defense using the same or substantially similar art and arguments against these claims harder for Cisco or its privies due to potential res judicata or collateral estoppel effects, though a denial based on Fintiv does not trigger statutory estoppel under 35 U.S.C. § 315(e).

Strategic summary

All claims (1-20) of US11576046 remain UNTESTED by the PTAB on their merits, as the sole IPR filed against it, IPR2026-00209, was denied institution on discretionary grounds under the Fintiv framework. This means that no claims have been canceled or sustained in a Final Written Decision from the PTAB. The patent's validity, as challenged in this specific IPR, was not substantively decided by the Board.

Regarding the estoppel landscape, since IPR2026-00209 was denied institution, statutory estoppel under 35 U.S.C. § 315(e)(2) does not apply to Cisco Systems, Inc. or its privies for the grounds raised in the petition. However, the PTAB's discretionary denial, particularly one based on Fintiv, often signals that the Board prefers to allow district court litigation to proceed. While the specific grounds of unpatentability articulated in the petition were not judged, a defendant facing assertion of this patent would need to carefully consider the reasoning behind the discretionary denial if planning to file a new IPR with similar grounds and/or face similar parallel litigation. For other potential petitioners not in privity with Cisco, all prior-art grounds remain theoretically available for future IPR challenges, assuming institution criteria are met.

The activity shows a single IPR filing by Cisco Systems, Inc., which was ultimately denied institution. This doesn't establish a pattern of aggressive PTAB appeals by the patent owner, Damaka Inc., nor does it indicate the involvement of a defensive aggregator at this stage.

Recommended next steps

  • A defendant currently facing assertion of US11576046 should review the "Institution Decision" for IPR2026-00209 to understand the specific reasoning for the discretionary denial, particularly the PTAB's application of the Fintiv factors. The decision can be found on the USPTO PTAB E2E portal using the proceeding number IPR2026-00209. This will inform any strategy for challenging the patent's validity at the PTAB, especially if there is ongoing or anticipated district court litigation.
  • Given that the IPR was denied institution, the claims of US11576046 have not been substantively reviewed by the PTAB. If a defendant wishes to challenge the patent, a new IPR petition, potentially with different prior art or arguments, or a strategy that addresses the Fintiv concerns (e.g., timing relative to district court litigation), would need to be considered.
  • There are no active proceedings pending against US11576046 at the PTAB. This absence of further PTAB activity after the initial denial suggests that, as of now, the claims remain entirely untransformed by AIA trials.

Generated 5/28/2026, 6:46:25 AM